CTi Biopharma Corp (CTIC) Financials

$9.09

$0.00 (0.00%)

As on 26-Jun-2023 09:30EDT

Market cap

$1,199 Mln

Revenue (TTM)

$76 Mln

P/E Ratio

--

P/B Ratio

112.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	75.77	53.95	--	0.00	3.35	26.29
Cost of Revenue	4.46	3.51	0.16	4.20	--	0.88
Gross Profit	71.31	50.43	-0.16	-4.20	3.35	25.41
Operating Expenses	125.24	130.23	95.33	47.77	43.26	57.65
Operating Profit (EBIT)	-53.93	-79.80	-95.33	-47.77	-40.71	-32.90
Other Income	-0.05	-0.06	--	-4.17	1.69	4.76
Profit before Tax	-69.24	-92.99	-97.91	-52.45	-40.02	-29.35
Provision for Tax	7.77	-1.95	1.73	0.50	2.29	5.28
Profit after Tax (Net Income)	-77.01	-91.04	-99.64	-52.95	-42.32	-29.32
Minority Interest	--	--	--	--	0.00	-0.03
Consolidated Profit	-69.24	-92.99	-97.91	-52.45	-40.02	-29.40

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-25.35	-17.58	3.77	40.03	17.93	58.69
Minority Interest	--	--	--	--	-5.76	-5.76
Non-Current Liabilities	69.39	62.37	2.02	1.17	9.86	13.84
Current Liabilities	68.23	81.13	66.65	17.04	18.49	23.06
Total Liabilities	180.50	125.93	72.43	58.24	46.28	89.83

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	25.82	26.53	4.06	3.92	10.70	7.34
Current Assets	86.45	99.40	68.38	54.33	35.58	82.49
Total Assets	180.50	125.93	72.43	58.24	46.28	89.83
Total Debt*	48.90	49.96	50.56	5.26	12.26	14.08
Net Current Assets	18.23	18.26	1.73	37.29	17.09	59.44

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-81.19	-84.89	-42.21	-27.82	-39.82
Cash Flow from Investing Activities	--	-73.85	12.00	-9.62	28.13	-30.49
Cash from Financing Activities	--	120.02	97.94	61.07	-5.61	63.49
Net Cash Inflow / Outflow	--	-35.03	--	9.25	-5.30	-6.82

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.65	-0.79	-1.11	-0.75	-0.73	-0.52
Cash EPS ($)	--	-0.77	-1.10	-0.74	-0.72	-0.51
Adjusted Book Value ($)	--	--	0.04	0.56	0.31	1.05
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.71	-0.94	-0.59	-0.48	-0.71
Free Cash Flow per Share ($)	--	-0.92	-0.94	-0.59	-0.48	-0.71

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-210.00	-200.06	-140.32	-82.20	-53.99
ROE (%)	--	1,318.48	-455.00	-182.72	-110.45	-72.84
ROA (%)	-37.49	-91.79	-152.49	-101.32	-62.18	-40.52
EBIT Margin (%)	-71.18	-147.91	--	-1,137,357.14	-1,217.07	-104.93
Net Margin (%)	-101.71	-168.93	--	1,270.78	-840.46	-94.44
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3,201.48	--	-1.00	-1.00	-0.87	0.05
EBIT Growth (%)	52.48	16.30	-99.57	-17.34	-47.58	28.60
Net Profit Growth (%)	35.42	8.63	-88.17	-25.13	-44.33	27.91
EPS Growth (%)	48.85	0.28	-0.48	-0.02	-0.39	0.54
Book Value Growth (%)	31.22	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-7.59	-2.24	-4.32	-2.17	-1.40
Price / Book Value	112.63	-39.32	59.25	5.71	5.11	0.70
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.68	-8.28	-2.18	-3.81	-1.88	0.44
Close Price ($)	4.20	6.01	2.48	3.22	1.58	0.73
High Price ($)	7.80	7.80	4.13	4.03	1.93	5.36
Low Price ($)	3.32	1.82	1.43	0.62	0.63	0.60
Market Cap ($ Cr)	1,198.79	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-2.84	13.42	0.13	0.68	0.24
Short term debt to equity ratio	-1.93	-2.77	12.89	0.11	0.27	0.08
Current Ratio	1.27	1.23	1.03	3.19	1.92	3.58
Quick Ratio	1.26	1.22	--	--	--	--
Interest Coverage	-3.13	-6.07	-39.47	-46.29	-26.73	-15.91

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	30.30	28.52	--	--	--	52.03
Asset Turnover	0.37	0.54	--	0.00	0.05	0.36
Receivable days	--	104.18	--	--	746.82	103.93
Inventory Days	--	76.19	--	--	--	228.54
Payable days	--	306.58	6,270.50	575.83	--	1,472.22
Cash Conversion Cycle	--	-126.21	--	--	--	-1,139.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.